Biol stock forecast.

Find the latest Financials data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.

Biol stock forecast. Things To Know About Biol stock forecast.

Their UBX share price targets range from $4.00 to $10.00. On average, they anticipate the company's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 226.6% from the stock's current price. View analysts price targets for UBX or view top-rated stocks among Wall Street analysts.Find real-time BLUE - bluebird bio Inc stock quotes, company profile, news and forecasts from CNN Business.Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.Get The Latest SYN Stock Analysis, Price Target, Earnings Estimates, and Headlines at MarketBeat. ... In Vitro Toxicology Testing Market Global Forecast to 2028. November 17, 2023 | finance.yahoo.com ... Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA.Find the latest ProShares Ultra Bloomberg Natural Gas (BOIL) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.

Stock Price Forecast. The 3 analysts offering 12-month price forecasts for BIOLASE Inc have a median target of 3.00, with a high estimate of 40.00 and a low estimate of 2.50. The median estimate represents a +143.90% increase from the last price of 1.23.BIOL Overview Stock Screener Earnings Calendar Sectors Nasdaq | BIOL U.S.: Nasdaq Biolase Inc. Watch list Set a price target alert After Hours Last Updated: Nov 24, 2023 4:47 p.m. EST...

Quotes Summary Real-Time After-Hours Key Data Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest …Stock Price Forecast. The 3 analysts offering 12-month price forecasts for BIOLASE Inc have a median target of 3.00, with a high estimate of 40.00 and a low estimate of 2.50. The median estimate represents a +143.90% increase from the last price of 1.23.$ 1.208013 1-Month Prediction $ 1.531689 3-Month Prediction Unlock 6-Month Prediction Unlock 1-Year Prediction Unlock Loading... According to our current BIOL stock …A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for Cybin stock is $4.00, which predicts an increase of 769.57%. The lowest target is $3.00 and the highest is $5.00. On average, analysts rate Cybin stock as a strong buy.

Find the latest ADMA Biologics, Inc. (ADMA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

Dec 1, 2023 · Full Company Report for BIOL. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 3.29B. -13.94%. Get the latest Roche Holding AG (RO) real-time quote, historical ...How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997. Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average ...Price Prediction BIOLASE price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.Find the latest stock market trends and activity today. Compare key indexes, including Nasdaq Composite, Nasdaq-100, Dow Jones Industrial & more.Ticker: BIOL. Sector: Healthcare. Closing price of the last trading day: $1.66. Last trading day: 10/25/2023. Analyst forecast price: $20.5. 52-week high/low: $23.48 / $3.3. Shares of BIOLASE, Inc. are traded on the stock exchange under the ticker BIOL, marking their space in the competitive " Healthcare " sector.

Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.1500 +0.0600 (+5.50%) At close: 03:59PM EST 1.1300...Financials. Next reporting date. February 1, 2024. EPS forecast (this quarter) $0.45. Annual revenue (last year) $1.1B. Annual profit (last year)For Biolase Inc Stock (BIOL) price forecast for 2024, the average price target for Biolase Inc Stock is $21.75 with a high forecast of $42.41 and a low forecast of $1.0934. The average BIOL price prediction of 2024 represents a +1,639% increase from the last price of $1.2506. Amgen ( AMGN, $252.17), founded in 1980, is a pioneer in biologics. Total product sales accounted for 93.5% of AMGN's 2021 revenues. The company's three top-selling drugs are Enbrel for ...

Nov 21, 2023 · Target values for the price of one BIOLASE share for Aug 2024. The weighted average target price per BIOLASE share in Aug 2024 is: 1.67. In Aug, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 14.327% volatility is expected. Pessimistic target level: 1.51. Optimistic target level: 1.77. BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 13, 2023 · About BIOLASE (NASDAQ:BIOL) Stock BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...52,938.42. -121.12. -0.23%. NBI | A complete Nasdaq Biotechnology Index index overview by MarketWatch. View stock market news, stock market data and trading information.Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...4 equities research analysts have issued 1-year price objectives for Fortress Biotech's stock. Their FBIO share price targets range from $15.00 to $75.00. On average, they predict the company's stock price to reach $55.00 in the next year. This suggests a possible upside of 2,582.9% from the stock's current price.Ticker: BIOL. Sector: Healthcare. Closing price of the last trading day: $1.66. Last trading day: 10/25/2023. Analyst forecast price: $20.5. 52-week high/low: $23.48 / $3.3. Shares of BIOLASE, Inc. are traded on the stock exchange under the ticker BIOL, marking their space in the competitive " Healthcare " sector.The 1 Wall Street analysts offering Surface Oncology stock forecast in the last 6 months have average price target of $5.0 with a high forecast of $5.0 and a low forecast of $5.0. The average Surface Oncology stock forecast represents a 367.29% increase from the last price of $1.07000005245209. Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.7 Best-Performing Biotech ETFs for November 2023. Biotech and health care exchange-traded funds let you invest in dozens or even hundreds of companies working on groundbreaking treatments ...

BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 17, 2023 · BIOLASE (NASDAQ:BIOL) has a market capitalization of $3.32 million and generates $39.19 million in revenue each year. The medical technology company earns $-16,160,000.00 in net income (profit) each year or ($3.57) on an earnings per share basis.

The average Biora Therapeutics stock price prediction forecasts a potential upside of 3,932.26% from the current BIOR share price of $1.24. What is BIOR's forecast return on equity (ROE) for 2023-2026? (NASDAQ: BIOR) forecast ROE is …

3. Johnson & Johnson. There’s arguably no better bellwether in the healthcare sector than Johnson & Johnson, which is the biggest life sciences company in the world. J&J’s products include ...Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...Find the latest Leap Therapeutics, Inc. (LPTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Find real-time PTON - Peloton Interactive Inc stock quotes, company profile, news and forecasts from CNN Business.How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997.It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Bitcoin nears $40K, marking a dramatic year of growth amidst evolving market dynamics and investor optimism. Bitcoin’s Upward Trend: Nearing the $40K Landmark As Bitcoin (BTC) starts December 2023, excitement fills the crypto market. Bitcoin’s value has jumped up a lot. Now, investors are looking at the $40,000 mark.Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...1.62K. 100.03%. Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

BIOLASE, Inc. (BIOL) share price prediction for 2023, 2024, 2025, 2026 and 2027. BIOL one year forecast. Biolase stock monthly and weekly forecasts.Quotes Summary Real-Time After-Hours Key Data Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest …Find the latest Cabaletta Bio, Inc. (CABA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Instagram:https://instagram. nkla stock forecastbest book on communicationbing ai logo generatorbpi bank philippines Synthetic biology can solve our most pressing problems, and these three stocks are already doing it. By John Blankenhorn, InvestorPlace Contributor Aug 25, 2023, 5:11 pm EST. Synthetic biology ... will home heating oil prices go downnasdaq txrh Brickell Biotech, Inc. (NASDAQ:BBI) released its quarterly earnings data on Thursday, August, 11th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($1.48) by $1.47. Brickell Biotech had a negative trailing twelve-month return on equity of 156.10% and a negative net margin of 643.48%.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get... funded options trading account Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Oct 26, 2023 · With the interplay of data, predictions, and real-time performance, BIOLASE's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale. Dec 1, 2023 · The 12-month stock price forecast is $113.33, which is an increase of 9,594.61% from the latest price. Price Target ( 9,594.61% upside) Analyst Consensus: Strong Buy News All Videos Press Releases Conversation